These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1734944)

  • 1. Combined antitumor therapy with the chemotherapeutic drug doxorubicin and an anti-transferrin receptor immunotoxin: in vitro and in vivo studies.
    Griffin TW; Stocl M; Collins J; Fernandes J; Maher VE
    J Immunother (1991); 1992 Jan; 11(1):12-8. PubMed ID: 1734944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T; Raso V
    Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.
    Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V
    Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of antitumor immunotoxins by liposomal monensin.
    Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
    J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
    Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
    Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
    J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
    Zovickian J; Johnson VG; Youle RJ
    J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
    Recht LD; Griffin TW; Raso V; Salimi AR
    Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs.
    Liu C; Lambert JM; Teicher BA; Blättler WA; O'Connor R
    Blood; 1996 May; 87(9):3892-8. PubMed ID: 8611717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
    Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
    Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.
    FitzGerald DJ; Bjorn MJ; Ferris RJ; Winkelhake JL; Frankel AE; Hamilton TC; Ozols RF; Willingham MC; Pastan I
    Cancer Res; 1987 Mar; 47(5):1407-10. PubMed ID: 3493065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors.
    Bjorn MJ; Groetsema G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6639-45. PubMed ID: 3499979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
    Calvete JA; Newell DR; Wright AF; Rose MS
    Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R
    Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
    Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
    Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of a CD24-specific deglycosylated ricin-A-chain immunotoxin in conventional and novel models of small-cell-lung-cancer xenograft.
    Zangemeister-Wittke U; Lehmann HP; Waibel R; Wawrzynczak EJ; Stahel RA
    Int J Cancer; 1993 Feb; 53(3):521-8. PubMed ID: 8381397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cytotoxic efficacy of immunotoxins prepared from anti-CD5 antibody linked to ricin A-chain.
    Rostaing-Capaillon O; Casellas P
    Cancer Immunol Immunother; 1991; 34(1):24-30. PubMed ID: 1722138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin.
    Shaik MS; Jackson TL; Singh M
    J Pharm Pharmacol; 2003 Jun; 55(6):819-25. PubMed ID: 12841943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraventricular immunotoxin therapy for leptomeningeal neoplasia.
    Laske DW; Muraszko KM; Oldfield EH; DeVroom HL; Sung C; Dedrick RL; Simon TR; Colandrea J; Copeland C; Katz D; Greenfield L; Groves ES; Houston LL; Youle RJ
    Neurosurgery; 1997 Nov; 41(5):1039-49; discussion 1049-51. PubMed ID: 9361057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.